232 related articles for article (PubMed ID: 11199452)
1. [Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on Infections in Hematology and Oncology].
Kern WV; Beyer J; Böhme A; Buchheidt D; Cornely O; Einsele H; Kisro J; Krüger W; Maschmeyer G; Ruhnke M; Schmidt CA; Schwartz S; Szelenyi H;
Dtsch Med Wochenschr; 2000 Dec; 125(51-52):1582-8. PubMed ID: 11199452
[No Abstract] [Full Text] [Related]
2. [Infection prophylaxis in neutropenic patients].
Capdevila JA; Pahissa A
Enferm Infecc Microbiol Clin; 1997 Dec; 15(10):544-51. PubMed ID: 9522519
[No Abstract] [Full Text] [Related]
3. [Treatment of fungal infections in hematology and oncology. Guidelines of the Working Party on Infections in Hematology and Oncology (AGIHO) of the German Society for Hematology and Oncology (DGHO)].
Böhme A; Ruhnke M; Karthaus M; Einsele H; Guth S; Heussel G; Heussel CP; Junghanss C; Kern WV; Kubin T; Sezer O; Silling G; Südhoff T; Szelényi H; Ullmann AJ;
Dtsch Med Wochenschr; 2001 Dec; 126(50):1440-7. PubMed ID: 11743682
[No Abstract] [Full Text] [Related]
4. Antimicrobial prophylaxis for infection in neutropenic patients.
Bodey GP
Curr Clin Top Infect Dis; 1988; 9():1-43. PubMed ID: 3077285
[No Abstract] [Full Text] [Related]
5. [Prevention of bacterial and fungal infections in neutropenic patients with malignant hematologic diseases].
Candoni A; Russo D; Salmaso F
Clin Ter; 1997; 148(1-2):23-8. PubMed ID: 9377834
[TBL] [Abstract][Full Text] [Related]
6. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
Klastersky J
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
[TBL] [Abstract][Full Text] [Related]
7. [Antiinfectious prophylaxis in pediatric oncology. Work group "Quality Assurance" of Society for Pediatric Oncology and Hematology (GPOH)].
Graubner UB; Boos J; Creutzig U; Dörffel W; Lakomek M; Niemeyer C; Schrappe M; Spaar HJ; Belohradsky BH
Klin Padiatr; 1999; 211(4):347-52. PubMed ID: 10472574
[TBL] [Abstract][Full Text] [Related]
8. [Importance of prevention of infectious complications in pediatric hematologic-oncologic patients].
Fleischhack G; Simon A
Klin Padiatr; 2001 Sep; 213 Suppl 1():A5-8. PubMed ID: 11577360
[TBL] [Abstract][Full Text] [Related]
9. [Prevention and therapy of infections in tumor patients].
Burgmann H
Wien Med Wochenschr; 2001; 151(24):600-14. PubMed ID: 11820177
[TBL] [Abstract][Full Text] [Related]
10. Prevention and treatment of cancer-related infections.
Baden LR; Bensinger W; Angarone M; Casper C; Dubberke ER; Freifeld AG; Garzon R; Greene JN; Greer JP; Ito JI; Karp JE; Kaul DR; King E; Mackler E; Marr KA; Montoya JG; Morris-Engemann A; Pappas PG; Rolston K; Segal B; Seo SK; Swaminathan S; Naganuma M; Shead DA;
J Natl Compr Canc Netw; 2012 Nov; 10(11):1412-45. PubMed ID: 23138169
[TBL] [Abstract][Full Text] [Related]
11. [Antibiotics and antimycotics in oncology].
Krcméry V
Vnitr Lek; 1991; 37(7-8):695-702. PubMed ID: 1755212
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of infections in cancer patients with the help of antimicrobial agents].
Syrjänen J; Kujala P; Sinisalo M; Lumio J
Duodecim; 2002; 118(21):2233-9. PubMed ID: 12486960
[No Abstract] [Full Text] [Related]
13. Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Cornely OA; Böhme A; Buchheidt D; Glasmacher A; Kahl C; Karthaus M; Kern W; Krüger W; Maschmeyer G; Ritter J; Salwender HJ; Sandherr M; Schiel X; Schüttrumpf S; Sieniawski M; Silling G; Ullmann AJ; Wolf HH;
Ann Hematol; 2003 Oct; 82 Suppl 2():S186-200. PubMed ID: 13680164
[TBL] [Abstract][Full Text] [Related]
14. [Antimicrobial prophylaxis and therapy in neutropenia].
Link H
Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
[TBL] [Abstract][Full Text] [Related]
15. Comment on: Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
Cornely OA; Ullmann AJ; Karthaus M
J Antimicrob Chemother; 2006 Jan; 57(1):151-2; author reply 152-4. PubMed ID: 16314347
[No Abstract] [Full Text] [Related]
16. [Infectious complications following hematopoietic stem cell transplantation].
Akiyama H
Rinsho Ketsueki; 2008 Aug; 49(8):576-82. PubMed ID: 18800605
[No Abstract] [Full Text] [Related]
17. Updated guidelines for managing fungal diseases in hematology patients.
Hicheri Y; Toma A; Maury S; Pautas C; Mallek-Kaci H; Cordonnier C
Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1049-60. PubMed ID: 20818948
[TBL] [Abstract][Full Text] [Related]
18. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Summary and comments.
Sinkó J; Kullberg BJ; Edwards JE; Anaissie E
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i41-3. PubMed ID: 19372182
[No Abstract] [Full Text] [Related]
19. Antifungal prophylaxis and the rate of bacteremia among neutropenic patients.
Viscoli C; Paesmans M;
Clin Infect Dis; 2002 Jan; 34(2):289-91. PubMed ID: 11740722
[No Abstract] [Full Text] [Related]
20. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
Bow EJ; Laverdière M; Lussier N; Rotstein C; Cheang MS; Ioannou S
Cancer; 2002 Jun; 94(12):3230-46. PubMed ID: 12115356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
